Skip to main content
IFRX logo

InflaRx N.V.

IFRXNASDAQHealthcareBiotechnology

$1.58Today:- (-)1Y +25.41%

As of Oct 26, 2026 close

Market cap
$185.32M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$0.80$2.95
Volume (live)
-
Avg. volume (3M)
657.61K

InflaRx (IFRX) Income Statement

InflaRx reported revenue of EUR 29.33K in fiscal 2025 (fiscal year ended Dec 31, 2025), down 82.3% from EUR 165.79K a year earlier. InflaRx posted a net loss of EUR 45.63M, compared with a net loss of EUR 46.06M a year earlier. Gross margin was -24677.9% and operating margin -164525.5%.

InflaRx Income Statement Analysis

Values in millions EUR

Scroll to see more
InflaRx N.V. income statement - Annual data in millions EUR
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Mar 2020Dec 2018Dec 2017
Revenue & Gross Profit
Revenue0.030.170.060.000.000.000.000.000.00
Cost of Revenue7.273.320.530.000.000.000.000.180.07
Gross Profit-7.24-3.15-0.470.000.000.000.00-0.18-0.07
Operating Expenses
Research & Development25.7235.3641.0237.5335.7025.6844.5825.0314.42
Selling, General & Administrative17.5619.7816.1214.3411.987.9112.5012.795.14
Operating Expenses41.0249.8644.1332.2447.6333.9456.7737.5218.77
Operating Income-48.26-53.01-44.59-32.24-47.63-33.94-56.77-37.52-19.45
Other Income/Expense
Interest Income1.773.203.800.610.110.892.842.180.13
Interest Expense0.04-0.020.040.05-0.020.030.020.002.23
Other Income/Expense2.646.951.932.442.00-0.043.517.70-4.79
Income
Income Before Tax-45.62-46.06-42.67-29.48-45.63-33.98-53.25-29.81-24.24
Income Tax Expense0.01-0.010.000.000.000.000.000.000.00
Net Income-45.63-46.06-42.67-29.48-45.63-33.98-53.25-29.82-24.24
Net Income - Continuous Operations-45.63-46.06-42.67-29.48-45.63-33.98-53.25-29.82-24.24
Net Income - Discontinued Operations---------
EBITDA-45.16-52.95-42.06-28.84-47.34-33.59-56.48-37.34-19.58
EBIT-45.58-53.01-58.06-29.44-47.63-33.94---
Depreciation & Amortization0.420.060.570.530.300.350.290.170.07
Earnings Per Share
Basic EPS-1.00-1.00-1.00-1.00-1.00-1.00-2.00-1.00-1.00
Diluted EPS-1.00-1.00-1.00-1.00-1.00-1.00-2.00-1.00-1.00
Basic Shares Outstanding67.2958.9254.9444.2141.6327.0626.0025.1023.61
Diluted Shares Outstanding67.2958.9254.9444.2141.6327.0626.0025.1023.61

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About InflaRx Financial Statements

What was InflaRx's revenue in fiscal 2025?

InflaRx reported revenue of EUR 29.33K in fiscal 2025 (fiscal year ended Dec 31, 2025). That was down 82.3% from EUR 165.79K a year earlier.

Is InflaRx profitable?

No. InflaRx reported a net loss of EUR 45.63M in fiscal 2025. In fiscal 2024 it lost EUR 46.06M.

What is InflaRx's operating margin?

InflaRx's operating income was −EUR 48.26M on revenue of EUR 29.33K in fiscal 2025, an operating margin of -164525.5%, compared with -31973.7% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition